The Global Diabetes Market is Lucrative Despite the Major Drugs in the Market being Associated with Heart Risks
A new report from IMARC Group expects a strong uptake of DPP-IV Inhibitors and other new drug classes to drive sales in the Turkish Oral Antidiabetics market during 2011-2016
Driven by an increasing prevalence of diabetes, the total market for Insulin and Non-Insulin Antidiabetics is expected to reach sales worth US$ 2803 Million by 2015.
Page 1 of 1